Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Long-term outcome of paediatric-onset multiple sclerosis: a population-based study.
Colour vision impairment is associated with disease severity in multiple sclerosis.
The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells.
Head Tracking Latency in Virtual Environments Revisited: Do Users with Multiple Sclerosis Notice Latency Less?
Does levetircetam decrease of the rubral tremor in patients with multiple sclerosis.
Seizure characteristics in multiple sclerosis patients.
Association of SNPs of CD40 Gene with Multiple Sclerosis in Russians.
Higher macular volume in patients with MS receiving fingolimod: Positive outcome or side effect?
Functional brain imaging: an evidence-based analysis.
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis.
Detecting cognitive dysfunction in a busy multiple sclerosis clinical setting: a computer generated approach.
Fingolimod and multiple sclerosis: Four cautionary tales.
Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis.
Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability.
Polyomavirus JC infection inhibits differentiation of oligodendrocyte progenitor cells.
Interictal interleukin-17A levels are elevated and correlate with seizure severity of epilepsy patients.
Jugular Venous Flow Abnormalities in Multiple Sclerosis Patients Compared to Normal Controls.
Perceived cognitive decline in multiple sclerosis impacts quality of life independently of depression.
Correction: Comparative Study on the Therapeutic Potential of Neurally Differentiated Stem Cells in a Mouse Model of Multiple Sclerosis.
A new model of cuprizone-mediated demyelination/remyelination.
Occupational attainment as a marker of cognitive reserve in multiple sclerosis.
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
Vitamin D Therapy in Experimental Allergic Encephalomyelitis Could be Limited by Opposing Effects of Sphingosine 1-Phosphate and Gelsolin Dysregulation.
Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6.
Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells.
Pages
« first
‹ previous
…
348
349
350
351
352
353
354
355
356
…
next ›
last »